News

25 July 2008

TÜV SÜD acquires MSOURCE to enter life science clinical research

Mumbai. TÜV SÜD has completed the acquisition of all shares of MSOURCE Medical Development to create a new TÜV SÜD Life Science business unit. MSOURCE will be the contract research organization (CRO) of this business unit, which will belong to the PEOPLE division of TÜV SÜD. TÜV SÜD's dedication to product reliability, safety and quality now extends to the pharmaceutical and biotechnology industries. To the medical device industry, TÜV SÜD now additionally offers clinical research services.

MSOURCE employs more than 240 personnel, active in clinical trial management, data management, statistics, pharmacovigilance and quality assurance on behalf of pharmaceutical, biotechnology and medical device companies. Currently services are delivered from headquarters in Brussels/Kraainem and offices in the Netherlands, Germany, Poland, Spain and the UK.

"The opportunity to apply TÜV SÜD's certification, testing and management skills to clinical research services is the main reason to make this important step forward," said Prof. Dr. Peter Schaff, managing director of TÜV SÜD's PEOPLE Division. "There is a distinct need for quality in each step of the clinical research process, while the complexity and global reach of clinical trials increase every year.

"We are creating an important new Contract Research Organization with the stability of a major company, combined with the flexibility and responsiveness of a mid size CRO," said Dr. Adriaan Hart de Ruijter, co founder and managing director of MSOURCE. "We made the choice for TÜV SÜD because of a shared vision on quality and future strategy. The access to worldwide facilities and capital enables us to respond better to our client's needs". Dr. Hart de Ruyter assumes the role of managing director, TÜV SÜD Life Science, and will continue to lead the management team of MSOURCE as well as the further expansion to achieve global reach. MSOURCE will remain an independent organization and entity in the TÜV SÜD group. The headquarters of MSOURCE will remain in Kraainem, close to Brussels.

"Our employees will fit well into the PEOPLE division of TÜV SÜD. MSOURCE's mission to deliver excellence in clinical research services is close to TÜV SÜD's original corporate mission to support the design of technology for the benefit of people," said Dr. Anne Jolie, co founder and Manager Pharmacovigilance & Medical Affairs at MSOURCE.

For further details, email us at: info@tuv-sud.in